Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/06/034291
CTRI/2021/06/034291
Not yet recruiting
未知

Evaluating the effect of Duloxetine premedication on postoperative analgesic requirement in patients undergoing laparoscopic cholecystectomy surgery

Sharda Hospital School of Medical Sciences Research0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Sharda Hospital School of Medical Sciences Research
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Sharda Hospital School of Medical Sciences Research

Eligibility Criteria

Inclusion Criteria

  • •1\. All the elective cases of Laparoscopic Cholecystectomy of ASA I or II,
  • •scheduled for general anesthesia

Exclusion Criteria

  • •1\. Patient refusal
  • •2\. Patients with any known history of cardiovascular diseases 3\.Patients with known case of hepatic and renal disease
  • •4\.Patients with known history of substance abuse
  • •5\.A chronic opioid abuser( \>3 months), being on chronic Gabapentin or Pregabalin( \>3months)
  • •6\.Patients on antidepressant drugs and patients with psychiatric disorders 7\.Anticipitated difficult airway on preoperative assessment 8\.Patients converted to open cholecystectomy from laparoscopic cholecystectomy
  • •9\. Patients in whom drain placement has been done 10\.BMI \>30
  • •11\.Pregnant and lactating females
  • •12\.History of allergy to any of the drug to be administered

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
A clinical trial to assess the effect of combined duloxetine and tapentadol in pain of knee replacement surgeryHealth Condition 1: - Health Condition 2: M171- Unilateral primary osteoarthritisof knee
CTRI/2023/07/055550AIIMS Bhubaneswar
Not yet recruiting
Phase 3
Effect of Duloxetine in knee osteoarthritisOsteoarthritis of knee.Osteoarthritis of knee
IRCT20230821059204N1Mazandaran University of Medical Sciences60
Unknown
Phase 4
A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic PaiDiabetic Peripheral Neuropathic Pain
JPRN-jRCT1080222824Shionogi & Co., Ltd.
Completed
Not Applicable
The effect of Deluxitine on the negative symptoms of schizophrenia
IRCT20191218045795N2Sanandaj University of Medical Sciences44
Not yet recruiting
Phase 2
the effect of duloxetine on theanxiety and depression of patients with diabetic neuropathyCondition 1: Effect of Duloxetine on the Mental State of Patients (Anxiety) with Diabetic Neuropathy. Condition 2: Effect of Duloxetine on the Mental State of Patients (Depression) with Diabetic Neuropathy.Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathyE08.43
IRCT20210725051977N2Islamic Azad University30